SINTICKY DUCOTE: Open Payments
NPI 1770225856 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 28 payments from 13 companies in 2025. Trend: 2023 $293 · 2024 $646 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $331 |
| Edwards Lifesciences Corporation | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| JAZZ PHARMACEUTICALS INC. | 3 | $95 |
| Amgen Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| GENZYME CORPORATION | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $23 |
Products named: TEZSPIRE, AIRSUPRA, OFEV, XYWAV, DUPIXENT, NUCALA, GLASSIA, Ohtuvayre.
Industry payments across FL — which companies pay providers there.
